Post-approval studies (Phase 4)Study completedNCT00171977
What this trial is testing
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 64